<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Massey | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/dillhail6/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/dillhail6/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Massey.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">0369f4ec79aaeb6a344f9da8c8b86cd1</guid>
				<title>Massey posted an update: 5), haemodynamically relevant arrhythmias in 1.2% (95% CI [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/41906/</link>
				<pubDate>Sat, 08 Feb 2025 11:29:47 -0800</pubDate>

									<content:encoded><![CDATA[<p>5), haemodynamically relevant arrhythmias in 1.2% (95% CI 0.9-1.8) and in 2.1% (95% CI 1.6-2.8), AHF in 1.6% (95% CI 1.2-2.2) and in 4.2% (95% CI 3.4-5.1), spontaneous MI in 0.5% (95% CI 0.3-0.9) and in 1.6% (95% CI 1.2-2.2), and PMI in 13.2% (95% CI 11.9-14.7) and in 14.8% (95% CI 13.4-16.4) within 30 days and within 365 days, respectively. The&hellip;<span class="activity-read-more" id="activity-read-more-41906"><a href="http://www.nationalboardinstitute.com/activity/p/41906/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">69082c2816fed43cf1dc515ea8c0df70</guid>
				<title>Massey posted an update: 2% at 420 nm, which is one of the highest values among ZnIn2 [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40489/</link>
				<pubDate>Thu, 06 Feb 2025 16:47:14 -0800</pubDate>

									<content:encoded><![CDATA[<p>2% at 420 nm, which is one of the highest values among ZnIn2 S4 so far. <a href="https://www.selleckchem.com/products/ac-devd-cho.html" rel="nofollow ugc">N-Ac-Asp-Glu-Val-Asp-CHO</a> The synergistic effect of spatially separated dual cocatalysts and photothermal effect may be applied to other 2D materials for efficient solar energy conversion.</p>
<p> Home noninvasive positive pressure ventilation (NIPPV) has become a well-established&hellip;<span class="activity-read-more" id="activity-read-more-40489"><a href="http://www.nationalboardinstitute.com/activity/p/40489/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d1e9cfbc20bd82d1b83e6d915e6b1d64</guid>
				<title>Massey posted an update: Complexes 1 and 4 showed the greatest ability to inhibit the [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36747/</link>
				<pubDate>Sun, 02 Feb 2025 11:50:43 -0800</pubDate>

									<content:encoded><![CDATA[<p>Complexes 1 and 4 showed the greatest ability to inhibit the filamentation of C. albicans, which is an important process during fungal infection, and these two complexes efficiently inhibited the biofilm formation of C. albicans at subinhibitory concentrations. Complex 4 also successfully prevented the adhesion of C. albicans in an in vitro&hellip;<span class="activity-read-more" id="activity-read-more-36747"><a href="http://www.nationalboardinstitute.com/activity/p/36747/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ee8319830d001de58914b171219e36d1</guid>
				<title>Massey posted an update: nd much remains to be learned.



 Asthma is a common [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/34975/</link>
				<pubDate>Fri, 31 Jan 2025 12:22:43 -0800</pubDate>

									<content:encoded><![CDATA[<p>nd much remains to be learned.</p>
<p> Asthma is a common disease worldwide, however, its pathogenesis has not been fully elucidated. Emerging evidence suggests that epigenetic modifications may play a role in the development and natural history of asthma. The aim of this review is to highlight recent progress in research on epigenetic mechanisms in&hellip;<span class="activity-read-more" id="activity-read-more-34975"><a href="http://www.nationalboardinstitute.com/activity/p/34975/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">91c6ca17465fe68ee7e8080b8a12df04</guid>
				<title>Massey posted an update: To deliver counselling, PAL uses in-person and [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/31411/</link>
				<pubDate>Tue, 28 Jan 2025 16:51:30 -0800</pubDate>

									<content:encoded><![CDATA[<p>To deliver counselling, PAL uses in-person and telephone-based peer support, a tablet-delivered goal-setting tool and PCP training. Patients in the EUC arm receive non-tailored healthy living handouts. In-person data collection occurs at baseline, month 6 and month 12 for patients in both arms. Repeated measures modelling based on mixed models&hellip;<span class="activity-read-more" id="activity-read-more-31411"><a href="http://www.nationalboardinstitute.com/activity/p/31411/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">fea1e5d98a7afea8e42df2ecae4a0a7d</guid>
				<title>Massey became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/31361/</link>
				<pubDate>Tue, 28 Jan 2025 16:47:40 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>